DEC TIMOTHY C

CIK 00011940204 companiesCOLUMBIA, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001194020

Recent Transactions

50 trades

Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-08-22$44.49/sh−11,780→ 1,246 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-03-10$32.06/sh−955→ 12,681 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-03-10$32.06/sh−1,062→ 11,836 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-03-10+1,800→ 13,636 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2025-03-10−2,000→ 0 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-03-10+2,000→ 12,898 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2025-03-10−1,800→ 0 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-03-05$33.05/sh−276→ 13,815 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-03-05$33.05/sh−1,330→ 10,898 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-03-05$33.05/sh−1,587→ 12,228 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2025-02-28+1,800→ 1,800 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2025-02-28+2,000→ 2,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-23+2,500→ 14,091 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2025-02-23−2,500→ 5,000 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2025-02-22−3,000→ 9,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-22+500→ 8,591 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2025-02-22−500→ 500 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-22+3,000→ 11,591 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2025-02-19+40,000→ 40,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2025-02-19+4,500→ 4,500 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-02-23+2,500→ 8,504 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2024-02-23−2,500→ 7,500 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-02-23$29.06/sh−1,314→ 7,190 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2024-02-22−500→ 1,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2024-02-22+50,000→ 50,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2024-02-22+12,000→ 12,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-02-22+500→ 6,004 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2023-10-13+4,000→ 7,000 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2023-10-13$26.91/sh−1,911→ 5,089 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2023-10-13−4,000→ 0 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2023-10-04+4,000→ 4,000 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2023-05-11+1,500→ 3,359 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2023-05-11$36.47/sh−709→ 2,650 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Units
2023-05-11−1,500→ 0 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Units
2023-05-04+1,500→ 1,500 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2023-03-14−1,500→ 0 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2023-03-14$38.65/sh−789→ 2,052 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2023-03-14+1,500→ 2,841 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2023-02-23+40,000→ 40,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2023-02-23+10,000→ 10,000 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2023-02-22−500→ 1,500 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2023-02-22−500→ 1,500 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2023-02-22+500→ 1,341 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2023-02-22$38.57/sh−193→ 1,148 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2023-02-22+500→ 1,341 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2023-02-16+1,500→ 1,500 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2022-02-22+2,000→ 2,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2022-02-22+25,000→ 25,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2022-02-22+2,000→ 2,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2022-02-22+25,000→ 25,000 total

Companies

Recent Filings

Address

7226 LEE DEFOREST DRIVE SUITE 203

COLUMBIA, MD, 21046

View on SEC.gov